Home
Login
Help
Search this site:
Registered Trials
By recruitment status
By sponsor
By registration date
Advanced search for trials
Registration process
To register a trial
Sponsor registration form
RPCEC trial registration Data Set
To update a registered trial
To disclosure the results of registered trial
Home
|
By sponsor
CENTER OF MOLECULAR IMMUNOLOGY
Trials shown by sponsor
Public title
Date of Registration
State
Itolizumab for Moderate-to-Severe Psoriasis-phase 3
08/10/2015
Registered
Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory
09/07/2018
Registered
Phyisician Led CIMAvax-EGF lung biomarkers
11/03/2021
Registered outdated
CIMAvax-EGF in Bladder cancer
11/08/2020
Registered outdated
Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumab
12/05/2020
Registered outdated
CIMAvax-EGF in different maintenance schemes
12/05/2021
Registered outdated
NGcGM3/VSSP and nimotuzumab in patients with triple negative breast cancer
12/10/2016
Registered
CIMAvax-EGF vaccine Predictor Phase IV
14/12/2015
Registered outdated
EC122 HER-1 Prostate Phase I
15/11/2016
Registered
Racotumomab-alum cancer vaccine for solid tumors in pediatric patients
15/12/2015
Registered
Vaxira as adjuvant treatment for non-small cell lung cancer
15/12/2015
Registered outdated
Her1 vaccine in metastatic colon and prostate cancer
16/08/2023
Registered
Study of the mechanism of action of Nimotuzumab in patients with head and neck tumors
17/02/2017
Registered
CIMAvax-EGF® in metastatic asymptomatic or mildly symptomatic Castration Resistant Prostate Cancer patients. Phase II-III Clinical Trial
17/10/2018
Registered
Biomodulina T- CIMAvax-EGF-Advanced Non-Small Cell Lung Cancer-Adults
18/03/2021
Registered outdated
CIMAvax-EGF®-post-COVID19 convalescent with respiratory disorders-adults-Phase II (CORVAXCIM)
18/06/2021
Registered outdated
ior®EPOCIM in post-COVID-19 convalescent patients with cardiovascular, renal and/or respiratory disorders
18/06/2021
Registered outdated
NeuroEPO-Ataxia-Adults-Phase III
19/11/2020
Registered outdated
NeuroEPO in mild-moderate Alzheimer's disease
20/09/2022
Registered
CIMAvax-EGF/Lung cancer/Biomarkers/Prospective CT
20/10/2021
Registered
« first
‹ previous
1
2
3
4
5
next ›
last »
About the RPCEC
Structure and governance
Policy
Publications
Awards
Communications
News
Useful resources
Fundamentals of the registry
References of clinical trials
Cuban regulations
Other registries
International Clinical Trials Registry Platform